Shree Pushkar Chemicals Q4 FY26: Profit Slumps 22% as Margins Compress

2 hours ago
share
Share Via
Shree Pushkar Chemicals & Fertilisers Ltd., a Mumbai-based manufacturer of dyes, chemicals, and fertilisers, reported a disappointing fourth quarter for FY26, with net profit declining 22.19% year-on-year to ₹12.87 crores from ₹16.54 crores in the same period last year. The sequential decline was even steeper at 28.78%, falling from ₹18.07 crores in Q3 FY26. The stock reacted negatively to the results, declining 4.04% to ₹369.65 on May 19, extending its distance from the 52-week high of ₹476.60 reached last year.
Shree Pushkar Chemicals Q4 FY26: Profit Slumps 22% as Margins Compress
Net Profit (Q4 FY26)
₹12.87 Cr
▼ 22.19% YoY
Net Sales (Q4 FY26)
₹218.17 Cr
▼ 0.56% YoY
Operating Margin (Excl OI)
10.14%
▼ 112 bps YoY
PAT Margin
5.90%
▼ 164 bps YoY

The ₹1,190-crore market capitalisation company, which operates in the dyes and pigments sector, faced significant headwinds during the March 2026 quarter. Revenue remained virtually flat year-on-year but contracted sharply on a sequential basis, falling 12.33% from ₹248.86 crores in Q3 FY26 to ₹218.17 crores. This marked the lowest quarterly sales figure in the past year, signalling weakening demand conditions.

For the full year FY26, whilst complete annual figures are not yet available, the quarterly trend reveals mounting pressure. The company's operating margin excluding other income compressed to 10.14% in Q4 FY26 from 11.26% in Q4 FY25, whilst the profit after tax margin deteriorated by 164 basis points to 5.90% from 7.54% a year earlier.

Financial Performance: Margin Erosion Amplifies Profit Decline

The company's financial performance in Q4 FY26 was characterised by a combination of revenue stagnation and margin compression. Net sales of ₹218.17 crores represented a marginal 0.56% decline year-on-year, but the sequential contraction of 12.33% from the previous quarter raised concerns about demand momentum heading into FY27.

Quarter Net Sales (₹ Cr) QoQ Change Net Profit (₹ Cr) QoQ Change Operating Margin
Mar'26 218.17 -12.33% 12.87 -28.78% 10.14%
Dec'25 248.86 -2.44% 18.07 -0.71% 8.87%
Sep'25 255.09 +0.23% 18.20 -13.17% 10.29%
Jun'25 254.51 +16.00% 20.96 +26.72% 11.44%
Mar'25 219.40 +1.08% 16.54 +3.89% 11.26%
Dec'24 217.06 +23.60% 15.92 +19.52% 10.34%
Sep'24 175.62 13.32 10.86%

Operating profit before depreciation, interest, and tax (excluding other income) stood at ₹22.12 crores in Q4 FY26, representing a margin of 10.14%—down from 11.26% in the year-ago quarter. This margin compression was driven by elevated operating expenses that outpaced revenue growth. Employee costs rose to ₹15.73 crores from ₹14.15 crores year-on-year, representing an 11.17% increase.

The profit before tax declined 14.38% year-on-year to ₹17.44 crores from ₹20.37 crores, whilst the tax rate surged to 26.20% from 18.80% in Q4 FY25. This 740 basis point increase in the effective tax rate further pressured bottom-line profitability, contributing to the steep 22.19% decline in net profit.

Revenue (Q4 FY26)
₹218.17 Cr
▼ 0.56% YoY | ▼ 12.33% QoQ
Net Profit (Q4 FY26)
₹12.87 Cr
▼ 22.19% YoY | ▼ 28.78% QoQ
Operating Margin (Excl OI)
10.14%
Mar'25: 11.26%
PAT Margin
5.90%
Mar'25: 7.54%

Operational Challenges: Lowest Quarterly Sales in a Year

The company's operational performance in Q4 FY26 reflected mounting challenges across multiple fronts. Net sales of ₹218.17 crores marked the lowest quarterly revenue figure in the past year, falling below even the March 2025 quarter's ₹219.40 crores. This sequential revenue decline of 12.33% from Q3 FY26 suggests weakening demand conditions as the fiscal year drew to a close.

The balance sheet as of March 2025 (latest available) showed shareholder funds of ₹538.88 crores, with virtually no long-term debt at ₹0.16 crores. The company maintained a net cash position with a negative net debt-to-equity ratio of -0.01, indicating strong financial stability. However, current liabilities surged to ₹283.35 crores from ₹195.52 crores in the previous year, driven primarily by a significant increase in trade payables to ₹157.21 crores from ₹73.90 crores.

Key Concern: Deteriorating Profitability Metrics

The company's return on equity stood at 10.65% on average over recent years, with the latest figure at 12.39%. Whilst the ROE has shown some improvement, it remains relatively modest for a manufacturing company in a niche sector. The return on capital employed averaged 11.54%, with the latest figure at 13.87%, indicating moderate capital efficiency. These profitability metrics, whilst positive, are not exceptional and have been pressured by the recent margin compression.

Cash flow from operations for FY25 stood at ₹37.00 crores, down significantly from ₹50.00 crores in FY23, reflecting challenges in working capital management. Changes in working capital consumed ₹36.00 crores during FY25, representing a substantial drag on operational cash generation. The company deployed ₹34.00 crores towards investing activities during the year, primarily for capital expenditure.

Industry Context: Underperforming a Struggling Sector

The dyes and pigments sector has faced considerable headwinds over the past year, with the industry delivering a negative 14.38% return. However, Shree Pushkar Chemicals managed to outperform its sector significantly, posting a one-year return of 25.71%—an outperformance of 40.09 percentage points. This relative strength, however, has begun to fade in recent months as the company's fundamental performance deteriorated.

The broader chemicals sector has grappled with multiple challenges including raw material price volatility, subdued demand from key end-user industries, and intense competition. Chinese imports have continued to pressure domestic manufacturers, whilst environmental compliance costs have risen. Against this backdrop, Shree Pushkar's Q4 FY26 results reflect these industry-wide pressures manifesting in compressed margins and weaker volumes.

Quality Assessment: Average Grade with Structural Strengths

The company carries an "Average" quality grade based on long-term financial performance. Key structural strengths include zero promoter pledging, minimal debt (net cash company), strong interest coverage of 24.95 times, and healthy five-year sales growth of 24.80%. However, the relatively modest return on equity of 10.65% and the recent negative financial trend limit the quality assessment. The company's institutional holding remains negligible at just 0.72%, indicating limited participation from sophisticated investors.

Peer Comparison: Valuation Premium Amid Profitability Concerns

Shree Pushkar Chemicals trades at a price-to-earnings ratio of 17.04 times trailing twelve-month earnings, which appears reasonable relative to the sector. However, this valuation multiple must be viewed in the context of deteriorating profitability trends and compressed margins. The company's price-to-book value ratio of 2.07 times is notably higher than most peers in the dyes and pigments space.

Company P/E (TTM) P/BV ROE (%) Debt/Equity Div Yield (%)
Sh.Pushkar Chem. 17.04 2.07 10.65 -0.01 0.54
Sudarshan Chem NA (Loss Making) 1.91 10.08 0.35 0.52
Kiri Industries NA (Loss Making) 0.77 8.98 0.30
Ultramarine Pig. 15.14 1.14 7.13 0.02
Bodal Chemicals 28.53 0.77 4.57 0.75
Sudarshan Colora 15.81 1.41 9.05 -0.37

Shree Pushkar's return on equity of 10.65% ranks amongst the highest in its peer group, with only Sudarshan Chemicals posting a comparable figure of 10.08%. This superior capital efficiency has historically justified the company's valuation premium. However, the recent deterioration in profitability raises questions about the sustainability of this premium, particularly as margins have compressed and growth momentum has stalled.

The company's debt-free status (net cash position) represents a significant competitive advantage over peers such as Bodal Chemicals (0.75 debt-to-equity) and Kiri Industries (0.30). This financial flexibility provides Shree Pushkar with the capacity to navigate industry downturns and invest in growth opportunities without the burden of interest obligations. The dividend yield of 0.54% is modest, reflecting a conservative payout ratio of 11.03%.

Valuation Analysis: Fair Value but Momentum Concerns Persist

At the current market price of ₹369.65, Shree Pushkar Chemicals trades at what appears to be a "Fair" valuation based on historical metrics and peer comparison. The price-to-earnings ratio of 17.04 times is below the industry average of 32 times, suggesting a valuation discount. However, this discount may be justified given the company's recent negative financial trend and deteriorating profitability metrics.

The stock has corrected 22.44% from its 52-week high of ₹476.60, but remains 35.20% above its 52-week low of ₹273.40. The valuation grade changed to "Fair" from "Expensive" in November 2025, reflecting market recognition of the challenging operating environment. The enterprise value-to-EBITDA multiple of 11.93 times appears reasonable for a company with modest growth prospects and average quality characteristics.

P/E Ratio (TTM)
17.04x
Industry: 32x
Price to Book
2.07x
Book Value: ₹166.64
Dividend Yield
0.54%
Payout: 11.03%
EV/EBITDA
11.93x
Fair valuation

The PEG ratio of 0.87 suggests the stock is reasonably valued relative to its growth prospects, with a reading below 1.0 traditionally indicating potential undervaluation. However, this metric must be interpreted cautiously given the recent negative financial trend and the sequential decline in profitability. The forward outlook remains clouded by margin pressures and uncertain demand conditions in the dyes and pigments sector.

Shareholding Pattern: Stable Promoter Base, Limited Institutional Interest

The shareholding pattern has remained remarkably stable over the past five quarters, with promoter holding steady at 69.36%. The Makharia family, led by Bhanu Gopi Makharia (55.34%), maintains strong control over the company with no pledging of shares—a positive indicator of promoter confidence and financial stability.

Category Mar'26 Dec'25 Sep'25 Jun'25 QoQ Change
Promoters 69.36% 69.36% 69.36% 69.36%
FII 0.43% 0.59% 1.47% 0.42% -0.16%
Mutual Funds 0.00% 0.00% 0.00% 0.00%
Insurance 0.00% 0.00% 0.00% 0.00%
Other DII 0.29% 0.38% 0.00% 0.00% -0.09%
Non-Institutional 29.92% 29.67% 29.17% 30.22% +0.25%

Foreign institutional investor holdings have declined sequentially from 0.59% in December 2025 to 0.43% in March 2026, suggesting reduced interest from sophisticated global investors. The complete absence of mutual fund holdings (0.00%) is particularly noteworthy, indicating that domestic institutional investors have not found the stock compelling enough to establish positions. This lack of institutional participation may contribute to lower liquidity and higher volatility.

The non-institutional shareholding category, which includes retail investors and high-net-worth individuals, has increased marginally to 29.92% in March 2026. The stable promoter base combined with minimal institutional interest creates a shareholding structure that is heavily dependent on retail participation—a pattern that can lead to higher price volatility during periods of negative news flow.

Stock Performance: Strong Long-Term Returns Mask Recent Weakness

Despite the disappointing Q4 FY26 results, Shree Pushkar Chemicals has delivered impressive long-term returns to shareholders. Over the past three years, the stock has generated returns of 100.95%, significantly outperforming the Sensex return of 21.82% by 79.13 percentage points. The five-year return of 113.55% compares favourably against the Sensex return of 50.70%, representing alpha of 62.85 percentage points.

Period Stock Return Sensex Return Alpha
1 Day -4.04% -0.15% -3.89%
1 Week -0.12% +0.86% -0.98%
1 Month +6.45% -4.19% +10.64%
3 Months +5.90% -8.85% +14.75%
6 Months -10.02% -11.72% +1.70%
YTD -6.22% -11.76% +5.54%
1 Year +25.71% -8.36% +34.07%
2 Years +93.03% +1.61% +91.42%
3 Years +100.95% +21.82% +79.13%
5 Years +113.55% +50.70% +62.85%

However, the recent performance paints a more concerning picture. The stock is down 10.02% over the past six months and has declined 6.22% year-to-date in 2026. The one-month return of 6.45% provided some respite, but the 4.04% decline following the Q4 results announcement suggests that investors are growing increasingly concerned about the deteriorating fundamental trajectory.

The stock currently trades below all key moving averages—5-day (₹376.61), 20-day (₹380.04), 50-day (₹342.31), 100-day (₹344.34), and 200-day (₹366.47)—indicating weak technical momentum. The technical trend has shifted to "Sideways" from "Mildly Bearish" as of May 8, 2026, suggesting indecision amongst market participants. With a beta of 1.50, the stock exhibits higher volatility than the broader market, amplifying both gains and losses.

Investment Thesis: Quality Concerns Overshadow Valuation Comfort

The investment case for Shree Pushkar Chemicals presents a mixed picture characterised by structural strengths offset by deteriorating near-term fundamentals. The company's debt-free balance sheet, stable promoter holding with zero pledging, and reasonable valuation multiples provide some comfort. However, these positives are increasingly overshadowed by concerning operational trends.

Valuation
Fair
P/E: 17x | P/BV: 2.07x
Quality Grade
Average
Modest ROE: 10.65%
Financial Trend
Negative
Profit declined 22.19% YoY
Technical Trend
Sideways
Below all key MAs

The proprietary Mojo Score of 37 out of 100 places the stock firmly in "Sell" territory, down from a "Hold" rating just one day earlier. This sharp downgrade reflects the market's negative reaction to the Q4 FY26 results and the deteriorating financial trend. The score has declined significantly from 74 in September 2025, when the stock carried a "Buy" rating during a period of stronger operational performance.

"The company's transition from a 'Buy' to 'Sell' rating within eight months underscores the rapid deterioration in fundamentals and the market's diminishing confidence in near-term recovery prospects."

Key Strengths & Risk Factors

✓ Key Strengths

  • Debt-Free Balance Sheet: Net cash position with debt-to-equity of -0.01 provides financial flexibility and eliminates interest burden
  • Strong Long-Term Track Record: Five-year sales CAGR of 24.80% demonstrates historical growth capability
  • Zero Promoter Pledging: Stable 69.36% promoter holding with no pledged shares indicates strong promoter confidence
  • Robust Interest Coverage: EBIT-to-interest ratio of 24.95 times provides substantial cushion
  • Diversified Product Portfolio: Presence across chemicals, dyes, fertilisers, and cattle feed reduces concentration risk
  • Reasonable Valuation: P/E of 17x below industry average of 32x offers relative value
  • Superior ROE vs Peers: 10.65% ROE ranks amongst highest in peer group

⚠ Key Concerns

  • Sharp Profit Decline: Q4 FY26 net profit fell 22.19% YoY and 28.78% QoQ, indicating deteriorating profitability
  • Margin Compression: Operating margin contracted 112 bps YoY; PAT margin down 164 bps
  • Weakening Revenue Momentum: Sequential revenue decline of 12.33% signals demand weakness
  • Negative Financial Trend: Quarterly trend classified as "Negative" with lowest sales in past year
  • Elevated Tax Rate: Effective tax rate surged to 26.20% from 18.80%, pressuring net margins
  • Zero Institutional Participation: No mutual fund or insurance holdings; minimal FII interest at 0.43%
  • High Volatility: Beta of 1.50 indicates above-market volatility; stock classified as "High Risk High Return"

Outlook: What to Watch in Coming Quarters

Positive Catalysts

  • Revenue Recovery: Sequential improvement in quarterly sales above ₹240 crores would signal demand stabilisation
  • Margin Expansion: Operating margin returning to 11-12% range would restore profitability trajectory
  • Institutional Interest: Entry of mutual funds or increase in FII holdings would validate investment thesis
  • Working Capital Improvement: Reduction in trade payables and better cash flow generation
  • Tax Rate Normalisation: Return to 18-20% effective tax rate would boost net profitability

Red Flags to Monitor

  • Further Revenue Decline: Q1 FY27 sales below ₹210 crores would confirm negative trend
  • Continued Margin Pressure: Operating margin falling below 10% would be highly concerning
  • Rising Working Capital: Further deterioration in cash flow from operations
  • Promoter Stake Dilution: Any reduction in 69.36% promoter holding would be negative
  • Debt Accumulation: Loss of net cash status through increased borrowings

The immediate focus for investors should be on the Q1 FY27 results, expected in August 2026, which will provide critical insights into whether the Q4 FY26 weakness was a temporary blip or the start of a sustained downturn. Management commentary on demand conditions, order book visibility, and margin outlook will be particularly important. The company's ability to maintain its debt-free status whilst navigating this challenging period will be crucial to preserving investor confidence.

The Verdict: Deteriorating Fundamentals Warrant Caution

SELL

Score: 37/100

For Fresh Investors: Avoid initiating positions at current levels. The negative financial trend, margin compression, and sequential profit decline present significant near-term risks. Wait for at least two consecutive quarters of improvement in revenue and profitability before considering entry. The fair valuation does not compensate for deteriorating fundamentals and lack of institutional support.

For Existing Holders: Consider reducing exposure or exiting positions, particularly if holding unrealised gains from the strong multi-year rally. The sharp downgrade in Mojo Score from 74 to 37 within eight months signals rapidly deteriorating fundamentals. The 22.19% year-on-year profit decline and lowest quarterly sales in a year suggest the positive momentum has reversed. Use any technical bounce towards ₹380-390 levels to exit.

Fair Value Estimate: ₹340-360 (8% downside from current levels) based on 15-16x P/E on normalised earnings of ₹20-22 per share, assuming margins stabilise at 10-11% operating level.

Note– ROCE= (EBIT - Other income)/(Capital Employed - Cash - Current Investments)

⚠️ Investment Disclaimer

This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results. The analysis is based on publicly available information as of May 19, 2026, and market conditions may change rapidly.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News